Resultados de la búsqueda 921-930 of 10676 for Holistic Approach

  1. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...

  2. Salud de los consumidores Responden los expertos - Mayo Clinic

    Hazte cargo de tu salud. Conoce tus opciones. Utiliza sabiamente los medicamentos y suplementos. Infórmate y haz preguntas a tus profesionales de atención ...

  3. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate whether primary palliative care is an alternative strategy to specialty palliative care for improving ...

  4. Oncología (médica) - Ensayos clínicos

    This study aims to evaluate the outcomes and patient satisfaction with same day mastectomy with or without alloplastic reconstruction following COVID-19 and ...

  5. aerospace medicine_your faa medical evaluation_ART-20018264

    Si aún no has solicitado un examen físico para pilotos en Mayo Clinic o no tienes una cita médica ya confirmada, tan solo ponte en contacto con un coordinador ...

  6. Hematología - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...

  7. Dermatología - Ensayos clínicos

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This is a survey study to describe how women with Lynch syndrome are being screened for gynecologic cancer risk, their perception of cancer ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

  10. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...